PA
AROW icon

PharVision Advisers’s Arrow Financial AROW Stock Holding History

PharVision Advisers’s Portfolio AROW Stock Details AROW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-9,559
Closed -$300K – 136
2025
Q4 		$300K Buy
+9,559
New +$283K 0.15% 268

Other funds holding AROW

AF
Arrow Financial Glens Falls, New York $994M AUM 17.21% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

PharVision Advisers's AROW Position: Q1 2026 in Review

PharVision Advisers sold out of Arrow Financial (AROW) in Q1 2026, closing a stake of 9,559 shares — an estimated $300K sold.

PharVision Advisers first reported a position in AROW in Q4 2025 and held it in 1 quarter. The position peaked at $300K in Q4 2025. 139 funds tracked by Wall St. Rank hold AROW as of Q1 2026.

  • PharVision Advisers reported no remaining Arrow Financial position as of Q1 2026 after selling out during the quarter.
  • PharVision Advisers sold 9,559 Arrow Financial shares in Q1 2026, an estimated $300K.
  • PharVision Advisers first reported a position in Arrow Financial in Q4 2025 and held it in 1 quarter.
  • PharVision Advisers's Arrow Financial position peaked at $300K in Q4 2025.
  • 139 funds tracked by Wall St. Rank held Arrow Financial as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.